Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 3Phase NA 1Phase 2 1Phase 1 1

Status

Completed 4

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Neoplasms 66Breast Neoplasms 64Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 40Neoplasm Metastasis 23Colorectal Neoplasms 21Multiple Myeloma 20Pain 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Anemia 16Keratosis, Actinic 15Lung Neoplasms 14Cancer Pain 14Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 11Leukemia 11Leukemia, Lymphocytic, Chronic, B-Cell 10Carcinoma, Renal Cell 10Carcinoma, Hepatocellular 9Carcinoma 9Neuroendocrine Tumors 8Melanoma 8Lymphoma 8Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Uterine Cervical Neoplasms 6Recurrence 6Gastrointestinal Stromal Tumors 6Stomatitis 5Stomach Neoplasms 5

Interventions

Imiquimod 2tirbanibulin 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Keratosis × Clear all
NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT00116649 2010-07-20

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Graceway Pharmaceuticals, LLC

Phase 4 Completed
551 enrolled 11 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT00110682 2008-04-24

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

Derm Research @ 888 Inc.

Phase 4 Completed
60 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

NCT00115154 2007-02-19

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Graceway Pharmaceuticals, LLC

Phase 4 Completed
270 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡